Efficacy and safety of ivonescimab in non-small cell lung cancer: a systematic review and meta-analysis of emerging clinical data

Key Points

• Efficacy of ivonescimab shows promising results in treating non-small cell lung cancer, indicating a potential new therapy.
• The meta-analysis identified significant outcomes across emerging clinical data sets, highlighting ivonescimab's role.
• Systematic review included various clinical trials assessing ivonescimab in diverse non-small cell lung cancer populations.
• These findings may guide future therapeutic strategies for lung cancer, but further investigations are needed.

Abstract